Know Labs, Inc. Logo

Know Labs, Inc.

KNW

(0.5)
Stock Price

0,21 USD

-585.15% ROA

4632.08% ROE

-1.35x PER

Market Cap.

28.080.520,00 USD

-121.5% DER

0% Yield

0% NPM

Know Labs, Inc. Stock Analysis

Know Labs, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Know Labs, Inc. Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

2 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

3 ROE

Negative ROE (-342.27%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-404.75%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 PBV

The stock's elevated P/BV ratio (27.36x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

6 DER

The stock is burdened with a heavy load of debt (344%), making it financially unstable and potentially risky for investors.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-97) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Know Labs, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Know Labs, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Know Labs, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Know Labs, Inc. Revenue
Year Revenue Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 2.542.627 100%
2011 9.136.216 72.17%
2012 7.923.976 -15.3%
2013 8.572.799 7.57%
2014 7.983.352 -7.38%
2015 6.290.794 -26.91%
2016 6.023.600 -4.44%
2017 4.874.359 -23.58%
2018 4.303.296 -13.27%
2019 1.804.960 -138.42%
2020 121.939 -1380.22%
2021 0 0%
2022 4.360.087 100%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Know Labs, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2005 153.579
2006 468.730 67.24%
2007 550.008 14.78%
2008 0 0%
2009 214.105 100%
2010 90.900 -135.54%
2011 133.941 32.13%
2012 176.944 24.3%
2013 1.169.281 84.87%
2014 670.742 -74.33%
2015 362.661 -84.95%
2016 325.803 -11.31%
2017 79.405 -310.31%
2018 570.514 86.08%
2019 1.257.872 54.64%
2020 2.033.726 38.15%
2021 3.969.972 48.77%
2022 5.385.586 26.29%
2023 7.727.467 30.31%
2024 5.313.372 -45.43%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Know Labs, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 4.613.571 100%
2021 6.146.801 24.94%
2022 -3.422.319.863 100.18%
2023 6.844.616.000 150%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Know Labs, Inc. EBITDA
Year EBITDA Growth
2005 -853.032
2006 -1.007.050 15.29%
2007 -552.677 -82.21%
2008 -708.806 22.03%
2009 -897.048 20.98%
2010 -931.645 3.71%
2011 -1.874.572 50.3%
2012 -1.865.578 -0.48%
2013 -3.496.456 46.64%
2014 -2.143.092 -63.15%
2015 -1.976.723 -8.42%
2016 -2.514.403 21.38%
2017 -2.178.548 -15.42%
2018 -2.099.962 -3.74%
2019 -4.763.226 55.91%
2020 -6.517.172 26.91%
2021 -10.245.341 36.39%
2022 -11.731.451 12.67%
2023 -15.289.167 23.27%
2024 -15.153.840 -0.89%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Know Labs, Inc. Gross Profit
Year Gross Profit Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 447.136 100%
2011 1.566.210 71.45%
2012 1.579.729 0.86%
2013 1.855.607 14.87%
2014 1.289.078 -43.95%
2015 1.016.460 -26.82%
2016 987.901 -2.89%
2017 907.752 -8.83%
2018 821.623 -10.48%
2019 426.547 -92.62%
2020 52.213 -716.94%
2021 -200.807 126%
2022 929.649 121.6%
2023 -313.019 396.99%
2024 -189.496 -65.19%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Know Labs, Inc. Net Profit
Year Net Profit Growth
2005 -868.643
2006 -1.032.036 15.83%
2007 -1.634.993 36.88%
2008 -945.066 -73%
2009 -950.609 0.58%
2010 -1.148.920 17.26%
2011 -2.409.756 52.32%
2012 -2.731.898 11.79%
2013 -6.621.894 58.74%
2014 -1.017.281 -550.94%
2015 -2.631.037 61.34%
2016 -1.746.495 -50.65%
2017 -3.901.232 55.23%
2018 -3.257.597 -19.76%
2019 -10.548.067 69.12%
2020 -19.723.092 46.52%
2021 -40.274.278 51.03%
2022 -27.568.414 -46.09%
2023 -20.443.050 -34.85%
2024 -16.413.840 -24.55%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Know Labs, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 -8
2006 -9 11.11%
2007 -15 35.71%
2008 -8 -100%
2009 -5 -40%
2010 -6 0%
2011 -8 37.5%
2012 -6 -33.33%
2013 -8 25%
2014 -1 0%
2015 -2 100%
2016 -1 -100%
2017 -1 0%
2018 0 0%
2019 -1 0%
2020 -1 0%
2021 -1 100%
2022 -1 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Know Labs, Inc. Free Cashflow
Year Free Cashflow Growth
2005 -800.822
2006 -770.493 -3.94%
2007 -317.454 -142.71%
2008 164 193669.51%
2009 5.120 96.8%
2010 -463.783 101.1%
2011 -1.433.351 67.64%
2012 -167.341 -756.55%
2013 -3.529.421 95.26%
2014 -1.379.397 -155.87%
2015 -239.877 -475.04%
2016 -3.397.171 92.94%
2017 -1.264.324 -168.69%
2018 -1.214.382 -4.11%
2019 -3.183.967 61.86%
2020 -3.983.937 20.08%
2021 -7.150.224 44.28%
2022 -7.775.276 8.04%
2023 -10.434.788 25.49%
2024 -2.579.736 -304.49%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Know Labs, Inc. Operating Cashflow
Year Operating Cashflow Growth
2005 -788.514
2006 -770.493 -2.34%
2007 -317.454 -142.71%
2008 164 193669.51%
2009 5.120 96.8%
2010 -440.968 101.16%
2011 -1.312.291 66.4%
2012 -58.174 -2155.8%
2013 -3.503.580 98.34%
2014 -1.379.397 -153.99%
2015 -239.877 -475.04%
2016 -3.373.734 92.89%
2017 -1.264.324 -166.84%
2018 -1.117.131 -13.18%
2019 -3.104.035 64.01%
2020 -3.913.803 20.69%
2021 -6.850.699 42.87%
2022 -6.919.808 1%
2023 -10.353.991 33.17%
2024 -2.526.080 -309.88%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Know Labs, Inc. Capital Expenditure
Year Capital Expenditure Growth
2005 12.308
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 22.815 100%
2011 121.060 81.15%
2012 109.167 -10.89%
2013 25.841 -322.46%
2014 0 0%
2015 0 0%
2016 23.437 100%
2017 0 0%
2018 97.251 100%
2019 79.932 -21.67%
2020 70.134 -13.97%
2021 299.525 76.58%
2022 855.468 64.99%
2023 80.797 -958.79%
2024 53.656 -50.58%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Know Labs, Inc. Equity
Year Equity Growth
2005 402.320
2006 -473.216 185.02%
2007 -1.478.333 67.99%
2008 -2.134.634 30.75%
2009 -1.366.462 -56.22%
2010 -1.851.818 26.21%
2011 -1.566.562 -18.21%
2012 202.423 873.91%
2013 -2.757.923 107.34%
2014 -3.408.587 19.09%
2015 -5.378.294 36.62%
2016 -2.809.494 -91.43%
2017 -3.960.791 29.07%
2018 -2.607.590 -51.89%
2019 -3.297.290 20.92%
2020 -1.914.911 -72.19%
2021 1.242.163 254.16%
2022 9.862.613 87.41%
2023 3.743.912 -163.43%
2024 -4.601.481 181.36%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Know Labs, Inc. Assets
Year Assets Growth
2005 535.730
2006 7.160 -7382.26%
2007 88.784 91.94%
2008 2.021 -4293.07%
2009 11.889 83%
2010 4.144.156 99.71%
2011 4.313.403 3.92%
2012 5.319.766 18.92%
2013 4.629.200 -14.92%
2014 3.220.938 -43.72%
2015 2.460.678 -30.9%
2016 2.630.845 6.47%
2017 1.188.371 -121.38%
2018 2.102.948 43.49%
2019 2.639.633 20.33%
2020 4.682.147 43.62%
2021 12.889.491 63.67%
2022 13.758.366 6.32%
2023 8.265.897 -66.45%
2024 2.742.208 -201.43%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Know Labs, Inc. Liabilities
Year Liabilities Growth
2005 133.410
2006 480.376 72.23%
2007 1.567.117 69.35%
2008 2.136.655 26.66%
2009 1.378.351 -55.02%
2010 5.995.974 77.01%
2011 5.879.965 -1.97%
2012 5.117.343 -14.9%
2013 7.387.123 30.73%
2014 6.629.525 -11.43%
2015 7.838.972 15.43%
2016 5.440.339 -44.09%
2017 5.149.162 -5.65%
2018 4.710.538 -9.31%
2019 5.936.923 20.66%
2020 6.597.058 10.01%
2021 11.647.328 43.36%
2022 3.895.753 -198.98%
2023 4.521.985 13.85%
2024 7.343.689 38.42%

Know Labs, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.19
Price to Earning Ratio
-1.35x
Price To Sales Ratio
0x
POCF Ratio
-1.97
PFCF Ratio
-0.31
Price to Book Ratio
-4.69
EV to Sales
0
EV Over EBITDA
-2.04
EV to Operating CashFlow
-2.91
EV to FreeCashFlow
-0.35
Earnings Yield
-0.74
FreeCashFlow Yield
-3.27
Market Cap
0,03 Bil.
Enterprise Value
0,03 Bil.
Graham Number
0.49
Graham NetNet
-0.06

Income Statement Metrics

Net Income per Share
-0.19
Income Quality
0.69
ROE
46.32
Return On Assets
-5.85
Return On Capital Employed
4.46
Net Income per EBT
1.01
EBT Per Ebit
1.05
Ebit per Revenue
0
Effective Tax Rate
-334.76

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-105.37
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.13
Free CashFlow per Share
-1.1
Capex to Operating CashFlow
-7.38
Capex to Revenue
0
Capex to Depreciation
193.27
Return on Invested Capital
-5112.13
Return on Tangible Assets
-5.85
Days Sales Outstanding
0
Days Payables Outstanding
-4589.22
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
-0.08
Inventory Turnover
0
Capex per Share
0.97

Balance Sheet

Cash per Share
0,03
Book Value per Share
-0,06
Tangible Book Value per Share
-0.06
Shareholders Equity per Share
-0.06
Interest Debt per Share
-4.92
Debt to Equity
-1.21
Debt to Assets
2.04
Net Debt to EBITDA
-0.24
Current Ratio
0.35
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
-3534753
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.2

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Know Labs, Inc. Dividends
Year Dividends Growth

Know Labs, Inc. Profile

About Know Labs, Inc.

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

CEO
Mr. Ronald P. Erickson J.D.
Employee
15
Address
500 Union Street
Seattle, 98101

Know Labs, Inc. Executives & BODs

Know Labs, Inc. Executives & BODs
# Name Age
1 Dr. James H. Anderson Jr., M.D.
Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory Board
70
2 Mr. Ronald P. Erickson J.D.
Founder, Chief Executive Officer, Treasurer & Chairman
70
3 Jordyn Hujar
Chief of Staff
70
4 Mr. Leonardo Trautwein
Chief Commercial Officer
70
5 Mr. Peter Joseph Conley
Chief Financial Officer & Senior Vice President of Intellectual Property
70

Know Labs, Inc. Competitors